Omalizumab in patients with severe asthma: the XCLUSIVE study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Omalizumab in patients with severe asthma: the XCLUSIVE study

Published:2011-08-09 Issue:4 Volume:6 Page:215-227
ISSN:1752-6981
Container-title:The Clinical Respiratory Journal
language:en
Short-container-title:The Clinical Respiratory Journal

Author:

Schumann Christian,Kropf Cornelia,Wibmer Thomas,Rüdiger Stefan,Stoiber Kathrin Magdalena,Thielen Antje,Rottbauer Wolfgang,Kroegel Claus

Publisher

Wiley

Subject

Genetics (clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1752-699X.2011.00263.x/fullpdf

Reference32 articles.

1. The global burden of asthma: executive summary of the GINA Dissemination Committee report;Masoli;Allergy,2004

2. Effects of climate change on environmental factors in respiratory allergic diseases;D'Amato;Clin Exp Allergy,2008

3. Environmental risk factors and allergic bronchial asthma;D'Amato;Clin Exp Allergy,2005

4. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma;Eur Respir J,2003

5. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation;Holgate;J Allergy Clin Immunol,2005

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omalizumab: a quarter of a century in the fight against T2-inflammatory diseases of upper and lower respiratory tract;Meditsinskiy sovet = Medical Council;2023-11-16

2. Ayurvedic Herbs Advised for COVID-19 Management: Therapeutic Potential and Clinical Relevance;Current Traditional Medicine;2023-08

3. Efficacy of two-year anti-IgE therapy in patients with severe allergic bronchial asthma in Sverdlovsk region;Meditsinskiy sovet = Medical Council;2023-04-11

4. The "real-world" effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study;Advances in Dermatology and Allergology;2023

5. Roles of real-world evidence in severe asthma treatment: challenges and opportunities;ERJ Open Research;2022-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3